Elegen

San Carlos, United States

Elegen is a biotechnology company that develops microfluidic technology.

$35.0M raised

May 2024

Series B

Top Investors

Andreessen Horowitz8VCTriatomic CapitalAgilent TechnologiesKdT Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Elegen raised?

Elegen has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in May 2024.

Who are Elegen's investors?

Elegen's investors include Andreessen Horowitz, 8VC, Triatomic Capital, Agilent Technologies, KdT Ventures.

Where is Elegen headquartered?

Elegen is headquartered in San Carlos, United States.

What does Elegen do?

Elegen is a biotechnology company that develops microfluidic technology.

What stage is Elegen at?

Elegen is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 14, 2024.

MLA

"Elegen — Funding & Investors." VCBacked, May 14, 2024, https://www.vcbacked.co/company/elegen. Accessed June 4, 2026.

APA

VCBacked. (2024). Elegen — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/elegen

Wikipedia (cite web)

{{cite web |title=Elegen — Funding & Investors |url=https://www.vcbacked.co/company/elegen |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 14, 2024.